{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T22:26:15Z","timestamp":1791584775282,"version":"4.3.4"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T00:00:00Z","timestamp":1658448000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T00:00:00Z","timestamp":1658448000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-022-04100-5","type":"journal-article","created":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T03:03:01Z","timestamp":1658458981000},"page":"899-907","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Aristolochic acid-containing Chinese herbal medicine and upper urinary tract urothelial carcinoma in Taiwan: a narrative review"],"prefix":"10.1007","volume":"41","author":[{"given":"Kathleen G.","family":"Dickman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4921-5315","authenticated-orcid":false,"given":"Chung-Hsin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur P.","family":"Grollman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeong-Shiau","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,22]]},"reference":[{"key":"4100_CR1","unstructured":"Ferlay J, Shen HR, Bray F, Forman D, Mathers C, Parkin DM (2008) Cancer incidence and mortality worldwide: IARC CancerBase No. 10"},{"key":"4100_CR2","doi-asserted-by":"publisher","first-page":"8241","DOI":"10.1073\/pnas.1119920109","volume":"109","author":"CH Chen","year":"2012","unstructured":"Chen CH, Dickman KG, Moriya M et al (2012) Aristolochic acid-associated urothelial cancer in Taiwan. Proc Natl Acad Sci USA 109:8241\u20138246","journal-title":"Proc Natl Acad Sci USA"},{"key":"4100_CR3","unstructured":"Bureau of Helath Promotion DoHT. The incidence of bladder, renal pelvic and ureteral tumor in Taiwan. https:\/\/cris.hpa.gov.tw\/pagepub\/Home.aspx?itemNo=cr.q.10. Accessed 24 Jan 2022"},{"key":"4100_CR4","unstructured":"Howlader NNA, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA (eds) SEER cancer statistics review, 1975\u20132011, National Cancer Institute. Bethesda, MD, http:\/\/seer.cancer.gov\/csr\/1975_2011\/. Based on November 2013 SEER data submission, posted to the SEER web site, April 2014. Accessed 24 Feb 2015"},{"key":"4100_CR5","first-page":"1296","volume":"55","author":"HY Chiou","year":"1995","unstructured":"Chiou HY, Hsueh YM, Liaw KF et al (1995) Incidence of internal cancers and ingested inorganic arsenic: a seven-year follow-up study in Taiwan. Can Res 55:1296\u20131300","journal-title":"Can Res"},{"key":"4100_CR6","unstructured":"Bureau of Health Promotion T (2019) Adult smoking behavior surveillance system"},{"key":"4100_CR7","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/0140-6736(93)92984-2","volume":"341","author":"JL Vanherweghem","year":"1993","unstructured":"Vanherweghem JL, Depierreux M, Tielemans C et al (1993) Rapidly progressive interstitial renal fibrosis in young women: association with slimming regimen including Chinese herbs. Lancet 341:387\u2013391","journal-title":"Lancet"},{"key":"4100_CR8","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/0140-6736(93)90404-5","volume":"341","author":"PPH But","year":"1993","unstructured":"But PPH (1993) Need for correct identification of herbs in herbal poisoning. Lancet 341:637","journal-title":"Lancet"},{"key":"4100_CR9","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1056\/NEJM200006083422301","volume":"342","author":"JL Nortier","year":"2000","unstructured":"Nortier JL, Martinez MC, Schmeiser HH et al (2000) Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi). N Engl J Med 342:1686\u20131692","journal-title":"N Engl J Med"},{"key":"4100_CR10","doi-asserted-by":"publisher","first-page":"12129","DOI":"10.1073\/pnas.0701248104","volume":"104","author":"AP Grollman","year":"2007","unstructured":"Grollman AP, Shibutani S, Moriya M et al (2007) Aristolochic acid and the etiology of endemic (Balkan) nephropathy. Proc Natl Acad Sci USA 104:12129\u201312134","journal-title":"Proc Natl Acad Sci USA"},{"key":"4100_CR11","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1749-8546-3-13","volume":"3","author":"SC Hsieh","year":"2008","unstructured":"Hsieh SC, Lin IH, Tseng WL, Lee CH, Wang JD (2008) Prescription profile of potentially aristolochic acid containing Chinese herbal products: an analysis of National Health Insurance data in Taiwan between 1997 and 2003. Chin Med 3:13","journal-title":"Chin Med"},{"key":"4100_CR12","unstructured":"Li SC (1578) Compendium of materia medica [Bencao Gangmu]"},{"key":"4100_CR13","unstructured":"Anonymous (200) Shennong's compendium of materia medica [Shen Nong Ben Cao Jing]"},{"key":"4100_CR14","unstructured":"Tao HJ (400) Annotated Shen Nong's Herbal [Bencaojing Jizhu]"},{"key":"4100_CR15","first-page":"35","volume":"8","author":"C Tong","year":"1999","unstructured":"Tong C (1999) Current status of misusage and replacement of Chinese herbs in Taiwan. J Chin Med 8:35\u201346","journal-title":"J Chin Med"},{"key":"4100_CR16","unstructured":"Chuang MS, Hsu YH, Chang HC, Lin JH, Liao CH (2001) Studies on adulteration and misusage of marketed akebiae caulis. Department of Health. Report No.: 20"},{"key":"4100_CR17","unstructured":"Huang LH (2011) The current status and development of Chinese herbal industry in Taiwan. Taiwan"},{"key":"4100_CR18","unstructured":"Health Do (2013) Statistics of National Health Insurance in Taiwan"},{"key":"4100_CR19","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1016\/S0731-7085(03)00310-8","volume":"33","author":"TT Jong","year":"2003","unstructured":"Jong TT, Lee MR, Hsiao SS et al (2003) Analysis of aristolochic acid in nine sources of Xixin, a traditional Chinese medicine, by liquid chromatography\/atmospheric pressure chemical ionization\/tandem mass spectrometry. J Pharm Biomed Anal 33:831\u2013837","journal-title":"J Pharm Biomed Anal"},{"key":"4100_CR20","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1016\/j.transproceed.2012.10.035","volume":"45","author":"GM Liu","year":"2013","unstructured":"Liu GM, Fang Q, Ma HS, Sun G, Wang XC (2013) Distinguishing characteristics of urothelial carcinoma in kidney transplant recipients between China and Western countries. Transpl Proc 45:2197\u20132202","journal-title":"Transpl Proc"},{"key":"4100_CR21","doi-asserted-by":"publisher","first-page":"6627","DOI":"10.2147\/CMAR.S178554","volume":"10","author":"G Xiong","year":"2018","unstructured":"Xiong G, Yao L, Hong P et al (2018) Aristolochic acid containing herbs induce gender-related oncological differences in upper tract urothelial carcinoma patients. Cancer Manag Res 10:6627\u20136639","journal-title":"Cancer Manag Res"},{"issue":"A8","key":"4100_CR22","first-page":"e1","volume":"57","author":"AJ Collins","year":"2011","unstructured":"Collins AJ, Foley RN, Herzog C et al (2011) US Renal Data System 2010 Annual Data Report. Am J Kidney Dis 57(A8):e1-526","journal-title":"Am J Kidney Dis"},{"key":"4100_CR23","first-page":"139","volume":"14","author":"SJY Huang","year":"2000","unstructured":"Huang SJY, Chen HH (2000) Annual report of dialysis from 1999 to 2000 in Taiwan. Acta Nephrol 14:139\u2013228","journal-title":"Acta Nephrol"},{"key":"4100_CR24","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/S0272-6386(00)70343-X","volume":"35","author":"CS Yang","year":"2000","unstructured":"Yang CS, Lin CH, Chang SH, Hsu HC (2000) Rapidly progressive fibrosing interstitial nephritis associated with Chinese herbal drugs. Am J Kidney Dis 35:313\u2013318","journal-title":"Am J Kidney Dis"},{"key":"4100_CR25","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1159\/000046647","volume":"21","author":"CH Chang","year":"2001","unstructured":"Chang CH, Wang YM, Yang AH, Chiang SS (2001) Rapidly progressive interstitial renal fibrosis associated with Chinese herbal medications. Am J Nephrol 21:441\u2013448","journal-title":"Am J Nephrol"},{"key":"4100_CR26","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/ijc.28013","volume":"133","author":"CH Chen","year":"2013","unstructured":"Chen CH, Dickman KG, Huang CY et al (2013) Aristolochic acid-induced upper tract urothelial carcinoma in Taiwan: clinical characteristics and outcomes. Int J Cancer J Int Cancer 133:14\u201320","journal-title":"Int J Cancer J Int Cancer"},{"key":"4100_CR27","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/S0929-6646(11)60026-0","volume":"110","author":"HY Yang","year":"2011","unstructured":"Yang HY, Wang JD, Lo TC, Chen PC (2011) Increased risks of upper tract urothelial carcinoma in male and female chinese herbalists. J Formosan Med Assoc Taiwan yi zhi 110:161\u2013168","journal-title":"J Formosan Med Assoc Taiwan yi zhi"},{"key":"4100_CR28","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.juro.2012.08.090","volume":"189","author":"HY Yang","year":"2013","unstructured":"Yang HY, Wang JD, Lo TC, Chen PC (2013) Occupational exposure to herbs containing aristolochic acids increases the risk of urothelial carcinoma in Chinese herbalists. J Urol 189:48\u201352","journal-title":"J Urol"},{"key":"4100_CR29","doi-asserted-by":"publisher","first-page":"17","DOI":"10.2188\/jea.JE20080035","volume":"19","author":"HY Yang","year":"2009","unstructured":"Yang HY, Wang JD, Lo TC, Chen PC (2009) Increased mortality risk for cancers of the kidney and other urinary organs among Chinese herbalists. J Epidemiol Jpn Epidemiol Assoc 19:17\u201323","journal-title":"J Epidemiol Jpn Epidemiol Assoc"},{"key":"4100_CR30","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1053\/j.ajkd.2009.10.055","volume":"55","author":"MN Lai","year":"2010","unstructured":"Lai MN, Lai JN, Chen PC, Hsieh SC, Hu FC, Wang JD (2010) Risks of kidney failure associated with consumption of herbal products containing Mu Tong or Fangchi: a population-based case-control study. Am J Kidney Dis 55:507\u2013518","journal-title":"Am J Kidney Dis"},{"key":"4100_CR31","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1093\/jnci\/djp467","volume":"102","author":"MN Lai","year":"2010","unstructured":"Lai MN, Wang SM, Chen PC, Chen YY, Wang JD (2010) Population-based case-control study of Chinese herbal products containing aristolochic acid and urinary tract cancer risk. J Natl Cancer Inst 102:179\u2013186","journal-title":"J Natl Cancer Inst"},{"key":"4100_CR32","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1002\/cncr.22557","volume":"109","author":"CH Chang","year":"2007","unstructured":"Chang CH, Yang CM, Yang AH (2007) Renal diagnosis of chronic hemodialysis patients with urinary tract transitional cell carcinoma in Taiwan. Cancer 109:1487\u20131492","journal-title":"Cancer"},{"key":"4100_CR33","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.urology.2011.01.007","volume":"77","author":"FP Hurst","year":"2011","unstructured":"Hurst FP, Jindal RM, Fletcher JJ et al (2011) Incidence, predictors and associated outcomes of renal cell carcinoma in long-term dialysis patients. Urology 77:1271\u20131276","journal-title":"Urology"},{"key":"4100_CR34","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jfma.2013.10.022","volume":"114","author":"SM Wang","year":"2015","unstructured":"Wang SM, Lai MN, Chen PC, Wang JD (2015) Increased risk of urothelial cancer in young and middle aged patients with end-stage renal disease. J Formosan Med Assoc Taiwan yi zhi 114:52\u201357","journal-title":"J Formosan Med Assoc Taiwan yi zhi"},{"issue":"3","key":"4100_CR35","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/dmrr.2614","volume":"31","author":"YS Tai","year":"2014","unstructured":"Tai YS, Chen CH, Huang CY, Tai HC, Wang SM, Pu YS (2014) Diabetes mellitus with poor glycemic control increases bladder cancer recurrence risk in patients with upper urinary tract urothelial carcinoma. Diabetes\/Metab Res Rev 31(3):307\u2013314","journal-title":"Diabetes\/Metab Res Rev"},{"key":"4100_CR36","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1053\/j.ajkd.2007.08.007","volume":"50","author":"SD Chung","year":"2007","unstructured":"Chung SD, Huang KH, Lai MK et al (2007) CKD as a risk factor for bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma. Am J Kidney Dis 50:743\u2013753","journal-title":"Am J Kidney Dis"},{"key":"4100_CR37","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1093\/carcin\/11.9.1627","volume":"11","author":"W Pfau","year":"1990","unstructured":"Pfau W, Schmeiser HH, Wiessler M (1990) 32P-postlabelling analysis of the DNA adducts formed by aristolochic acid I and II. Carcinogenesis 11:1627\u20131633","journal-title":"Carcinogenesis"},{"key":"4100_CR38","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1124\/dmd.105.008706","volume":"34","author":"H Dong","year":"2006","unstructured":"Dong H, Suzuki N, Torres MC et al (2006) Quantitative determination of aristolochic acid-derived DNA adducts in rats using 32P-postlabeling\/polyacrylamide gel electrophoresis analysis. Drug Metab Disposition Biol Fate Chem 34:1122\u20131127","journal-title":"Drug Metab Disposition Biol Fate Chem"},{"key":"4100_CR39","doi-asserted-by":"publisher","first-page":"4251","DOI":"10.1021\/ac400612x","volume":"85","author":"BH Yun","year":"2013","unstructured":"Yun BH, Rosenquist TA, Nikolic J et al (2013) Human formalin-fixed paraffin-embedded tissues: an untapped specimen for biomonitoring of carcinogen DNA adducts by mass spectrometry. Anal Chem 85:4251\u20134258","journal-title":"Anal Chem"},{"key":"4100_CR40","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1158\/1055-9965.EPI-20-1090","volume":"30","author":"CH Chen","year":"2021","unstructured":"Chen CH, Grollman AP, Huang CY et al (2021) Additive effects of arsenic and aristolochic acid in chemical carcinogenesis of upper urinary tract urothelium. Cancer Epidemiol Biomarkers Prev 30:317\u2013325","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"4100_CR41","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1158\/1055-9965.EPI-16-0219","volume":"25","author":"ML Hoang","year":"2016","unstructured":"Hoang ML, Chen CH, Chen PC et al (2016) Aristolochic acid in the etiology of renal cell carcinoma. Cancer Epidemiol Biomarkers Prev 25:1600\u20131608","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"4100_CR42","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1073\/pnas.0308607101","volume":"101","author":"Z Liu","year":"2004","unstructured":"Liu Z, Hergenhahn M, Schmeiser HH, Wogan GN, Hong A, Hollstein M (2004) Human tumor p53 mutations are selected for in mouse embryonic fibroblasts harboring a humanized p53 gene. Proc Natl Acad Sci USA 101:2963\u20132968","journal-title":"Proc Natl Acad Sci USA"},{"key":"4100_CR43","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.mrfmmm.2006.08.004","volume":"602","author":"N Mei","year":"2006","unstructured":"Mei N, Arlt VM, Phillips DH, Heflich RH, Chen T (2006) DNA adduct formation and mutation induction by aristolochic acid in rat kidney and liver. Mutat Res 602:83\u201391","journal-title":"Mutat Res"},{"key":"4100_CR44","doi-asserted-by":"publisher","first-page":"e11","DOI":"10.1053\/j.ajkd.2003.11.024","volume":"43","author":"GM Lord","year":"2004","unstructured":"Lord GM, Hollstein M, Arlt VM et al (2004) DNA adducts and p53 mutations in a patient with aristolochic acid-associated nephropathy. Am J Kidney Dis 43:e11\u2013e17","journal-title":"Am J Kidney Dis"},{"key":"4100_CR45","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/ki.2008.129","volume":"74","author":"FD Debelle","year":"2008","unstructured":"Debelle FD, Vanherweghem JL, Nortier JL (2008) Aristolochic acid nephropathy: a worldwide problem. Kidney Int 74:158\u2013169","journal-title":"Kidney Int"},{"key":"4100_CR46","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1002\/humu.10081","volume":"19","author":"M Olivier","year":"2002","unstructured":"Olivier M, Eeles R, Hollstein M, Khan MA, Harris CC, Hainaut P (2002) The IARC TP53 database: new online mutation analysis and recommendations to users. Hum Mutat 19:607\u2013614","journal-title":"Hum Mutat"},{"key":"4100_CR47","doi-asserted-by":"publisher","first-page":"197ra02","DOI":"10.1126\/scitranslmed.3006200","volume":"5","author":"ML Hoang","year":"2013","unstructured":"Hoang ML, Chen CH, Sidorenko VS et al (2013) Mutational signature of aristolochic acid exposure as revealed by whole-exome sequencing. Sci Transl Med 5:197ra02","journal-title":"Sci Transl Med"},{"key":"4100_CR48","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/ki.2011.371","volume":"81","author":"B Jelakovic","year":"2012","unstructured":"Jelakovic B, Karanovic S, Vukovic-Lela I et al (2012) Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid. Kidney Int 81:559\u2013567","journal-title":"Kidney Int"},{"key":"4100_CR49","first-page":"2025","volume":"56","author":"HH Schmeiser","year":"1996","unstructured":"Schmeiser HH, Bieler CA, Wiessler M, van Ypersele de Strihou C, Cosyns JP (1996) Detection of DNA adducts formed by aristolochic acid in renal tissue from patients with Chinese herbs nephropathy. Cancer Res 56:2025\u20132028","journal-title":"Cancer Res"},{"key":"4100_CR50","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.mrgentox.2006.02.017","volume":"608","author":"N Feldmeyer","year":"2006","unstructured":"Feldmeyer N, Schmeiser HH, Muehlbauer KR et al (2006) Further studies with a cell immortalization assay to investigate the mutation signature of aristolochic acid in human p53 sequences. Mutat Res 608:163\u2013168","journal-title":"Mutat Res"},{"key":"4100_CR51","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1002\/ijc.26077","volume":"129","author":"M Moriya","year":"2011","unstructured":"Moriya M, Slade N, Brdar B et al (2011) TP53 Mutational signature for aristolochic acid: an environmental carcinogen. Int J Cancer J Int Cancer 129:1532\u20131536","journal-title":"Int J Cancer J Int Cancer"},{"key":"4100_CR52","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1177\/030089161009600505","volume":"96","author":"R Cukuranovic","year":"2010","unstructured":"Cukuranovic R, Ignjatovic I, Visnjic M et al (2010) Characteristics of upper urothelial carcinoma in an area of Balkan endemic nephropathy in south Serbia. A fifty-year retrospective study. Tumori 96:674\u2013679","journal-title":"Tumori"},{"key":"4100_CR53","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0022-5347(05)00057-1","volume":"175","author":"S Holmang","year":"2006","unstructured":"Holmang S, Johansson SL (2006) Bilateral metachronous ureteral and renal pelvic carcinomas: incidence, clinical presentation, histopathology, treatment and outcome. J Urol 175:69\u201372 (discussion-3)","journal-title":"J Urol"},{"key":"4100_CR54","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1111\/j.1442-2042.2006.01429.x","volume":"13","author":"PC Huang","year":"2006","unstructured":"Huang PC, Huang CY, Huang SW et al (2006) High incidence of and risk factors for metachronous bilateral upper tract urothelial carcinoma in Taiwan. Int J Urol 13:864\u2013869","journal-title":"Int J Urol"},{"key":"4100_CR55","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1111\/j.1464-410X.2008.07438.x","volume":"101","author":"G Novara","year":"2008","unstructured":"Novara G, De Marco V, Dalpiaz O et al (2008) Independent predictors of metachronous bladder transitional cell carcinoma (TCC) after nephroureterectomy for TCC of the upper urinary tract. BJU Int 101:1368\u20131374","journal-title":"BJU Int"},{"key":"4100_CR56","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1021\/tx3000889","volume":"25","author":"BH Yun","year":"2012","unstructured":"Yun BH, Rosenquist TA, Sidorenko V et al (2012) Biomonitoring of aristolactam-DNA adducts in human tissues using ultra-performance liquid chromatography\/ion-trap mass spectrometry. Chem Res Toxicol 25:1119\u20131131","journal-title":"Chem Res Toxicol"},{"key":"4100_CR57","doi-asserted-by":"publisher","first-page":"981","DOI":"10.3109\/00498258709044197","volume":"17","author":"G Krumbiegel","year":"1987","unstructured":"Krumbiegel G, Hallensleben J, Mennicke WH, Rittmann N, Roth HJ (1987) Studies on the metabolism of aristolochic acids I and II. Xenobiotica Fate Foreign Compounds Biol Syst 17:981\u2013991","journal-title":"Xenobiotica Fate Foreign Compounds Biol Syst"},{"key":"4100_CR58","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1093\/carcin\/13.10.1835","volume":"13","author":"RC Fernando","year":"1992","unstructured":"Fernando RC, Schmeiser HH, Nicklas W, Wiessler M (1992) Detection and quantitation of dG-AAI and dA-AAI adducts by 32P-postlabeling methods in urothelium and exfoliated cells in urine of rats treated with aristolochic acid I. Carcinogenesis 13:1835\u20131839","journal-title":"Carcinogenesis"},{"key":"4100_CR59","doi-asserted-by":"publisher","first-page":"e32143","DOI":"10.7554\/eLife.32143","volume":"7","author":"SU Springer","year":"2018","unstructured":"Springer SU, Chen CH, Rodriguez Pena MDC et al (2018) Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy. Elife 7:e32143","journal-title":"Elife"},{"key":"4100_CR60","doi-asserted-by":"publisher","first-page":"19860","DOI":"10.1038\/s41598-019-56394-y","volume":"9","author":"JR Jhuang","year":"2019","unstructured":"Jhuang JR, Chiang CJ, Su SY, Yang YW, Lee WC (2019) Reduction in the incidence of urological cancers after the ban on chinese herbal products containing aristolochic acid: an interrupted time-series analysis. Sci Rep 9:19860","journal-title":"Sci Rep"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-022-04100-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-022-04100-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-022-04100-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T07:06:30Z","timestamp":1683183990000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-022-04100-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,22]]},"references-count":60,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,4]]}},"alternative-id":["4100"],"URL":"https:\/\/doi.org\/10.1007\/s00345-022-04100-5","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,22]]},"assertion":[{"value":"9 April 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declared no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"Not applicable. In this article, we systemically reviewed the published studies associated with aristolochic acid and did not reveal new information obtained from human or animal studies.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and animals"}},{"value":"Not applicable. This review article does not involve new human studies.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}